Mayo Clinic is committed to taking care of learners and staff during the COVID-19 pandemic.  Therefore, please be cognizant of, and abide by, any current guidelines regarding in-person gatherings, while following Mayo Clinic recommendations and CPD’s COVID-19 resources page.

DESCRIPTION
This is a weekly series held Monday, 7:30 - 8:30 am in Mayo 10-13

This is a multidisciplinary forum designed to enhance the practice and ensure excellence in all aspects of CAR-T cell therapy. We also discuss controversial cases as part of a patient selection process, presenting the data and literature in support and against proceeding with CAR-T cell therapy for a specific circumstance.

TARGET AUDIENCE
MD, APP/NP, Nursing, Human cell therapy, Pharmacy, Social work

LEARNING OBJECTIVES
Upon conclusion of this activity, participants should be able to:

• List an Innovation/Change in CAR-T cell therapy that is relevant to your daily practice
• Describe how this will impact your practice and what intervention is needed to optimize this change

Accreditation Statement
In support of improving patient care, Mayo Clinic College of Medicine and Science is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

AMA
The Mayo Clinic College of Medicine and Science designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credits^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

Disclosure Summary
As a provider accredited by Joint Accreditation Interprofessional Continuing Education, Mayo Clinic College of Medicine and Science (Mayo Clinic School of CPD) must ensure balance, independence, objectivity and scientific rigor in its educational activities. Course Director(s), Planning Committee Members, Faculty, and all others who are in a position to control the content of this educational activity are required to disclose all relevant financial relationships with any commercial interest related to the subject matter of the educational activity.  Safeguards against commercial bias have been put in place.  Faculty also will disclose any off label and/or investigational use of pharmaceuticals or instruments discussed in their presentation.  Disclosure of these relevant financial relationships will be published in activity materials so those participants in the activity may formulate their own judgments regarding the presentation.

Listed below are individuals with control of the content of this program who have disclosed...

Relevant financial relationship(s) with industry:

Stephen Ansell, MD, PhD
Grant/Research Support:  BMS, Seattle Genetics, Takeda, Regeneron, Affimed, AI Therapeutics, Trillium, ADC Therapeutics

Nabila Nora Bennani, MD
Grant/Research Support:  Kite/Gilead
Other:  Advisory board activity with the following:  Purdue Pharma, Kite/Gilead, Adicet Bio, Seattle Genetics

David Dingli, MD, PhD
Consultant: Janssen Therapeutics, Millennium/Takeda
Grant/Research Support:  Juno Therapeutics

Saad Kenderian, MD
Consultant:  Torque, CALIBR
Speaker’s Bureau:  Humanigen, Kite/Gilead, Novartis, Juno/BMS
Grant/Research Support:  Kite/Gilead, Novartis, Juno/BMS, Celgene, Humanigen, Tolero, Lentigen, Morphosys, Sunesis, Leahlabs
Other:  Patients and Royalties:  Novartis, Humanigen, Mettaforge

Shaji Kumar, MD
Consultant: Abbvie, Celgene, Janssen, Takeda, Adaptive, Kite, and MedImmune/Astra Zeneca
Grant/Research Support:  Research support to Institution from Abbvie, Celgene, Janssen, Merck, Novartis, Roche, Sanofi, and Takeda
Other:  Independent review committee participation for Oncopeptides.

Yi Lin, MD, PhD
Consultant: Kite/Gilead, Celgene/BMS, Juno/BMS, BlueBird Bio, Janssen, Legend BioTech, Gamida Cells, Novartis, Iovance, Takeda, Fosun Kite
Grant/Research Support:  Kite/Gilead, Celgene/BMS, BlueBird Bio, Janssen, Legend BioTech, Merck, Takeda, Boston Scientific. 
Other:  DSMB: Sorrento.  All funds paid to Mayo; no personal compensation.

Mithun Shah, MD, PhD
Consultant: Dren Bio, institutional reimbursement
Grant/Research Support:  ArcherDx

No relevant financial relationship(s) with industry:
Hassan Alkhateeb, MD
Matthew Bass
Suzanne R. Hayman, MD
Patrick Johnston, MD, PhD
Taxiarchis Kourelis, MD
Jonas Paludo, MD
Allison Rosenthal, DO
Rahma Warsame, MD

ATTENDANCE/CREDIT
Text the session code (provided only at the session) to 507-200-3010 within 48 hours of the live presentation to record attendance.  All learners are encouraged to text attendance regardless of credit needs.  This number is only used for receiving text messages related to tracking attendance.  Additional tasks to obtain credit may be required based on the specific activity requirements and will be announced accordingly. Swiping your badge will not provide credit; that process is only applicable to meet GME requirements for Residents & Fellows. 

TRANSCRIPT
Any credit or attendance awarded from this series will appear on your Transcript.

For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s), please go here. 

COURSE DIRECTOR
Yi Lin, MD, PhD

QUESTIONS?
Contact Matt Bass, Department Coordinator, at ph. 2-6614